Milnes Alistair (CIK 1901321) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-06). Recent activity: Buy BCYC (50,000 shares), Sell BCYC (3,244 shares), Sell BCYC (3,416 shares), Sell BCYC (1,147 shares), Sell BCYC (978 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-06 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF OPERATING OFFICER | Buy | 50,000 | $0 |
| 2026-01-06 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF OPERATING OFFICER | Sell | 3,244 | $22,059 |
| 2026-01-06 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF OPERATING OFFICER | Sell | 3,416 | $22,067 |
| 2025-10-06 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF OPERATING OFFICER | Sell | 1,147 | $9,635 |
| 2025-10-06 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF OPERATING OFFICER | Sell | 978 | $8,225 |
| 2025-07-07 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF OPERATING OFFICER | Sell | 1,149 | $8,146 |
| 2025-07-07 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF OPERATING OFFICER | Sell | 966 | $7,187 |
| 2025-04-04 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF OPERATING OFFICER | Sell | 1,133 | $9,087 |
| 2025-04-04 | BICYCLE THERAPEUTICS PLC (BCYC) | CHIEF OPERATING OFFICER | Sell | 1,038 | $7,764 |
Source: SEC Form 4 filings · as of 2026-01-06